Skip to main content
. 2015 Sep 23;2015(9):CD004249. doi: 10.1002/14651858.CD004249.pub4

Sloop 1982.

Methods Type of trial: RCT cross‐over design
 Number analysed/randomly assigned: 39/39
 Intention‐to‐treat analysis: calculated
Participants Subacute chronic neck pain with variable degenerative changes (cervical spondylosis)
Interventions INDEX TREATMENT
 Manipulation group (manip): technique: manipulation described by Cyriax, Maigne, Maitland, Matthews, muscle relaxant; frequency: 1 session; route: cervical spine
COMPARISON TREATMENT
 Control treatment (cntl): muscle relaxant
CO‐INTERVENTION: "other medical management was not restricted during the study"
Duration of treatment: 1 session
 Duration of follow‐up: 3 weeks (then cross‐over occurs)
Outcomes PAIN (neck pain intensity; VAS, 0 to 100)
 Baseline: NR
 Absolute benefit: manip 18, cntl 5
 Reported results: not significant
 SMD: 0.40 (95% CI ‐1.04 to 0.23) (power 5%)
FUNCTION (selected daily activities; VAS, 0 to 100)
 Baseline: NR
 Reported results: not significant
PATIENT SATISFACTION: NR
QoL: NR
GPE [patient perceived effect, 0 (completely well) to 8 (worst possible), collapsed to dichotomous response (improved/not improved)
 Reported results: not significant
 RR: 0.59 (95% CI 0.34 to 1.05)
SIDE EFFECTS: 2 people had superficial phlebitis following diazepam injection and recovered uneventfully; 2 people in the manipulation group reported new discomfort in their neck followed by improvement in their chronic neck pain
 RR: 1.0 (95% CI 0.4 to 2.4)
COST OF CARE: NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Page 533, column 1, paragraph 1
Allocation concealment (selection bias) Low risk Page 533, column 2, paragraph 2
Blinding of Participants (performance bias) Low risk Cross‐over design
Blinding of Personal (performance bias) High risk Not possible owing to design
Blinding of the Outcome assessor (detection bias) Low risk Page 533, column 2, paragraph 3
Incomplete outcome data (attrition bias) Low risk Page 534, column 1, paragraph 1
Randomized Participants analysed were allocated (attrition bias) Low risk Cross‐over design
Selective outcome (reporting bias) Unclear risk No reported protocol
Similar groups at baseline? Low risk Page 533, column 1, paragraph 5
co‐interventions avoided or similar? High risk Not reported
Compliance acceptable? Low risk Cross‐over design
Similar timing of outcome assessment? Low risk Baseline, 3 weeks, 12 weeks